Advarra analyzed 30,000+ studies to surface avoidable therapeutic-area-level trends for the research community.
Public source
Publisher name
Public post
Clinical data gets analyzed exhaustively, and it should be. It's what answers the research question. Operational data, the record of how a study ran, gets a fraction of…
Company
Advarra
We're making the protocol lifecycle intelligent.
- Industry
- Research Services
- Location
- Columbia, US
- Company size
- 1,001–5,000 employees
About Advarra
Advarra provides the platform, insights, and expertise that make clinical trials more efficient and connected. As the leading independent IRB, we bring more than 40 years of trusted oversight to the industry, setting the standard for ethical reviews while building the largest collection of digitized protocols and operational data. This combined intelligence guides the protocol’s entire journey—from design through review, activation, and conduct—fueling a smarter, more adaptive research ecosystem. Backed by decades of partnership with research sites, Advarra delivers the core systems and services that 50,000 investigators and their study teams depend on for optimal trial operations. Integrated with our solutions for study design, startup, and conduct, these capabilities create a collaborative technology platform trusted by sponsors and CROs globally. By designing AI-powered workflows that streamline operations, reduce administrative burden, and promote transparency for all study stakeholders, we’re reimagining what’s possible in clinical research.
See moreLatest activity
Latest activity from Advarra
12 signals
Research & Knowledge
Advarra published a trend report analyzing protocol amendments across over 30,000 clinical studies to help study teams design future studies.
Presence & Recognition
Advarra CEO Gadi Saarony shared four opportunities to strengthen clinical research in the U.S. during the ENRICH-CT session hosted by the Milken Institute.
Research & Knowledge
Advarra published a trend report analyzing protocol amendments across over 30,000 clinical studies to help study teams design future studies.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Clinical Research Pro | CRPro
Clinical Research Pro | CRPro has had to rescue or restart so many studies over the last year due to lack of regulatory and clinical operations experts.
Research & Knowledge
Clinical Trials Transformation Initiative (CTTI)
Clinical Trials Transformation Initiative (CTTI) released the Enabling Expedited Pathways booklet as the first deliverable from an ongoing effort to better understand the use of expedited programs for drugs, biologics, and devices.
Research & Knowledge
The Clinical Trials Network, (CTNx)
The Clinical Trials Network, (CTNx) published a blog post exploring modern protections such as Good Clinical Practice (GCP), IRB oversight, informed consent, and evolving approaches to accessibility and community engagement.
Research & Knowledge
Society for Clinical Research Sites (SCRS)
Society for Clinical Research Sites (SCRS) published the SCRS Site Invoiceables Guide to break down common billable items sites should consider when assessing trial-related costs.
Research & Knowledge
Health Research Authority